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Objective: To simulate the B1-inhomogeneity-induced variation of pharmacokinetic parameters on dynamic contrast-
enhanced magnetic resonance imaging (DCE-MRI).
Materials and Methods: B1-inhomogeneity-induced flip angle (FA) variation was estimated in a phantom study. Monte Carlo 
simulation was performed to assess the FA-deviation-induced measurement error of the pre-contrast R1, contrast-
enhancement ratio, Gd-concentration, and two-compartment pharmacokinetic parameters (Ktrans, ve, and vp).
Results: B1-inhomogeneity resulted in -23–5% fluctuations (95% confidence interval [CI] of % error) of FA. The 95% CIs of 
FA-dependent % errors in the gray matter and blood were as follows: -16.7–61.8% and -16.7–61.8% for the pre-contrast R1, 
-1.0–0.3% and -5.2–1.3% for the contrast-enhancement ratio, and -14.2–58.1% and -14.1–57.8% for the Gd-concentration, 
respectively. These resulted in -43.1–48.4% error for Ktrans, -32.3–48.6% error for the ve, and -43.2–48.6% error for vp. The 
pre-contrast R1 was more vulnerable to FA error than the contrast-enhancement ratio, and was therefore a significant cause 
of the Gd-concentration error. For example, a -10% FA error led to a 23.6% deviation in the pre-contrast R1, -0.4% in the 
contrast-enhancement ratio, and 23.6% in the Gd-concentration. In a simulated condition with a 3% FA error in a target 
lesion and a -10% FA error in a feeding vessel, the % errors of the pharmacokinetic parameters were -23.7% for Ktrans, -23.7% 
for ve, and -23.7% for vp.
Conclusion: Even a small degree of B1-inhomogeneity can cause a significant error in the measurement of pharmacokinetic 
parameters on DCE-MRI, while the vulnerability of the pre-contrast R1 calculations to FA deviations is a significant cause of 
the miscalculation.
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INTRODUCTION
Dynamic contrast-enhanced magnetic resonance imaging 
(DCE-MRI) is considered a useful tool for evaluating 
angiogenic alterations in various disease entities. As 
an advanced analysis technique, pharmacokinetic (PK)-
modeling on DCE-MRI can quantify the functional status 
of vessels, such as transvascular permeability and blood 
volume. Given this advantage, PK parameters using DCE-MRI 
are predicted to be promising biomarkers for assessing the 
response to antiangiogenic treatment (1-3). 
In order to accept the DCE-MRI-derived PK parameters 
as relevant indicators for predicting treatment response 
and patient prognosis, their measurement accuracy and 
reliability must necessarily be satisfied. In this regard, some 
steps in PK modeling have potential risks for significant 
misestimating (4). In particular, flip angle (FA) deviation 
due to a defectively transmitted radiofrequency field results 
in incorrect quantifications of the pre-contrast R1 and the 
Gd-driven contrast enhancement ratio (CER). As these two 
values are crucial elements in converting the DCE-MRI 
signal to the Gd-concentration for PK modeling (5-8), such 
miscalculation eventually leads to inaccurate and non-
reproducible estimation of PK parameters (7, 9-11).
Such unfavorable influence of B1-inhomogeneity on 
PK modeling of DCE-MRI has been demonstrated in many 
reports (5-8). However, the degree of error propagation 
led by the FA fluctuation in each modeling step has not 
been evaluated. This detailed information is important for 
establishing a strategy to minimize the measurement error 
and for understating the principle of error transfer and/or 
augmentation between the PK modeling processes. From 
this perspective, this study was conducted to investigate 
the actual range of B1-inhomogeneity and its impact on 
each computational process in PK modeling. Specifically, 
real FA variation measured on a clinical 3T MRI unit is 
applied to the Monte Carlo simulation that describes 
the B1-dependent, erroneous PK parameter estimation. 
Additionally, the extent of FA inhomogeneity is measured in 
normal volunteers in order to predict the FA-error-induced 
inaccuracy of PK parameters in clinical situations. Finally, 
the strategy to reduce such undesirable effects of B1-
inhomogeneity on PK modeling is discussed.
MATERIALS AND METHODS
Measurement of Ex Vivo and In Vivo B1 Error
All scans were performed on a Philips Achieva (ex vivo) 
and Ingenia (in vivo) 3T TX scanner (Philips Healthcare, 
Best, the Netherlands) that are used clinically and undergo 
regular equipment maintenance according to the vendor’s 
guidelines. The B1 transmission field was evaluated in a 
water phantom and in the brains of three normal volunteers, 
using a brain coil. The ‘actual flip angle imaging’ method, 
which uses two identical radiofrequency pulses with two 
different repetition times (TR1 < TR2) (12) was employed for 
measuring the B1-inhomogeneity. The steady-state gradient 
echo images were obtained according to the following 
parameters: TR1 = 30 ms, TR2 = 100 ms, echo time (TE) = 3.74 
ms, FA = 30, field of view = 200 x 200, and slice thickness 
= 5 mm in ex vivo experiments; and TR1 = 30 ms, TR2 = 120 
ms, TE = 2.2 ms, FA = 30, field of view = 230 x 180, and 
slice thickness = 5 mm in in vivo experiments. A FA map 
was then generated from these images, and the actual FA 
values were measured across the midline of the phantom 
and the brain. Finally, the means ± standard deviation (SD) 
and 95% confidence interval (CI), i.e., means ± 1.96 SD, of 
the actual FA were calculated.
Monte Carlo Simulation
From the 95% CI of actual FAs measured in the phantom 
study, 100000 FAs were randomly extracted with the 
assumption of their Gaussian distribution. These FAs were 
then applied to measure the actual values of the pre-
contrast R1 value, Gd-driven CER and the time-dependent 
Gd-concentration in the gray matter and blood. The B1-
dependent fluctuation of these values resulted in an 
incorrect estimation of the arterial input function (AIF) and 
the PK parameters, while the Levenberg-Marquardt method 
was used for fitting the time-Gd-concentration curve (13). 
All simulations were performed using MATLAB-based in-
house software (The MathWorks, Natick, MA, USA).
For quantifying the B1-dependent error, the % error was 
calculated using the following equation:
% error =
 Actual value - nominal (reference) value
Nominal (reference) value
 x 100 (1)
Pre-Contrast R1 Measurement
Flip angle-error-driven actual pre-contrast R1 values 
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for gray matter (reference value, 0.606 sec-1) and blood 
(reference value, 0.549 sec-1) were simulated using the 
variable flip angle (VFA) method (4, 14). For measuring the 
actual R1, two actual FAs corresponding to two nominal FAs 
of 2° and 14° were used by referring to the Quantitative 
Imaging Biomarker Alliance (QIBA) guidelines (15, 16).
The actual MR signal intensity (SI) determined by an 
erroneous FA was calculated as follows: 
SIa = M0∙sin αa∙
      1 - e-TR∙R1
 (2),
1 - cos αa∙e-TR∙R1
where SIa = FA-error-dependent actual SI, M0 = proton 
density, αa = actual FA corresponding to the nominal FA of 
2° and 14°, R1 = reference values of longitudinal relaxation 
rate (1 / T1) of gray matter and blood, and TR (2.5 msec). 
The actual R1 value was then calculated according to the 
following equations (17):
SIa / sin (αn) = m·SIa / tan (αn) + M0 (1 - m) (3),
e-R1∙TR = m (4),
where SIa = FA-error-dependent actual SI, αn is nominal FA, 
and TR (2.5 msec).
Gd-Driven CER
Gd-enhanced SI at a certain time-dependent Gd-
concentration was calculated according to the following 
equation: 
S (t) = M0∙sin α∙     
1 - e-TR∙(R1 + r1∙Cn [t]) (5),
1 - cos α∙e-TR∙(R1 + r1∙Cn [t])
where S (t) = Gd-enhanced, time-dependent SI, M0 = proton 
density (10000), R1 = pre-contrast R1 in the gray matter 
and blood, r1 = relaxivity of the Gd-based contrast agent 
(3.77 sec-1 mM-1), α = FA, Cn (t) = reference value of the 
time-dependent Gd-concentration. The Cn (t) was calculated 
according to the modified Tofts two-compartment model 
with reference parameter values as described in Eq-12, in 
which a1 = 3.99 kg/L, a2 = 4.78 kg/L, m1 = 0.144 min-1, 
m2 = 0.0111 min-1, D = 0.25 mM/kg, Ktrans = 0.05 min-1, ve 
= 0.21, and vp = 0.01 (6, 18, 19). In this computation, a 
TR of 2.5 msec and FA of 30° were applied by referring to 
the QIBA guidelines (16). An actual S (t) affected by the 
FA error was calculated by applying the actual FA and pre-
contrast R1, which were presented as ranges at each time 
point. In contrast, the nominal S (t) was also computed 
from the reference FA and pre-contrast R1. Consequently, 
the Gd-driven actual and nominal CERs, i.e., SIpost/SIpre, were 
simulated.
Conversion of SI to Gd-Concentration
MR SI can be converted to the Gd-concentration 
according to the follow equation:
C (t) = (R1 [t] - R1pre) / r1Gd (6),
E10 = e-R1pre∙TR (7),
B =
     1 - E10 (8),
1 - cos α∙E10
A = B∙CER (t) (9),
R1 (t) = 
-1
∙ln (
    1 - A     
) (10),
TR       1- cos α∙A
where C (t) = time-dependent Gd-concentration, CER (t) = 
Gd-driven CER, α = FA, TR = 2.5 msec, and R1 (t) = time-
dependent post-Gd R1 value. The actual Gd-concentration 
was calculated by applying the actual values of R1pre and 
CER (t), while the nominal Gd-concentration was calculated 
using the reference values. 
To compare the influence of a deviated pre-contrast 
R1 and CER on the Gd-concentration measurement, the 
variation of Gd-concentration was simulated while using the 
actual value of one parameter and the reference value of 
the other.
AIF
The time-dependent plasma concentration of Gd, i.e., AIF, 
was calculated using the following equation:
Cp (t) = D∙∑i = 1ai∙e-mi∙t (11),2
where Cp (t) = time-dependent Gd-concentration in the 
blood, D = the dose of CA (mmole/kg), ai = normalized for 
unit dose (kg/L), and mi = rate constant for the plasma 
curve (min-1). The actual a1, a2, m1, and m2 values were 
calculated by fitting the actual Cp (t), while the nominal Cp 
was calculated by applying the above-mentioned reference 
values.
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PK Parameters
The time-dependent concentration of Gd in the gray 
matter is described by the following equation:
Ct (t) = D∙Ktrans ∑i = 1  ai∙
e - [K
trans / ve]∙t - e-mi∙t
mi - [Ktrans / ve]
 + vp∙D∙∑i = 1 ai∙e
-mi∙t (12),
2
2
Fig. 1. Location-dependent distribution of B1-inhomogeneity-induced flip angle deviation measured in water phantom (A-C) and 
normal brain (D-F). Actual flip angle is greater than nominal flip angle at image center, whereas it was less at periphery. T1WI = T1-weighted 
image
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where Ct (t) = time-dependent tissue concentration 
of Gd, Ktrans = volume transfer constant between blood 
and extravascular extracellular space, ve = volume of 
extravascular extracellular space per unit volume of tissue, 
and vp = volume of plasma per unit volume of tissue. The 
nominal Ct (t) was generated using the above-mentioned 
reference values of Ktrans, ve, and vp, whereas the actual B1-
error-affected PK parameters were calculated by fitting the 
actual Ct (t). 
In order to describe an actual situation of B1-
inhomogeneity-driven error in PK modeling of DCE-MRI, 
a sample condition was simulated. With this process, a 
target lesion in the image center had a 3% FA deviation, 
and a feeding vessel in the image periphery had a -10% 
FA deviation. Under this condition, the measurement error 
occurring in each calculation step, which finally caused a 
variation of the PK parameters, was computed. 
RESULTS
Ex Vivo and In Vivo
B1-Inhomogeneity
The actual FA measured across the phantom and the brain 
of a normal volunteer is shown in Figure 1. The actual FA 
demonstrated a location-dependent distribution since it 
was greater than the nominal FA in the image center, but 
it was less in the peripheral area. In the phantom, the 
actual FA corresponding to the nominal FA of 30° was 27.4 
± 2.2° (mean ± SD; range, 23.3–32.1°). The 95% CI of the 
% error in the actual FA was -23–5% of the nominal FA. In 
three normal volunteers, the actual FA corresponding to the 
nominal FA of 30° was 32.5 ± 3.0° (range, 26.7–38.4°) and 
the 95% CI of the % error as -11–28% of the nominal FA.
Table 1. Simulation of B1-Error-Influenced Deviation
Gray Matter Blood
Precontrast R1
Reference value (sec-1) 0.549 0.606
Actual value (sec-1)
Mean ± SD 0.674 ± 0.110 0.743 ± 0.121
95% CI 0.458–0.889 0.505–0.981
Range 0.367–1.498 0.405–1.652
% error
Mean ± SD 22.59 ± 20.02 22.59 ± 20.02
95% CI -16.65–61.83 -16.65–61.82
Range -33.19–172.57 -33.18–172.55
Gd-driven CER
Difference between actual and nominal values
Mean ± SD -0.0105 ± 0.0099 -0.1881 ± 0.1764
95% CI -0.0298–0.0088 -0.5339–0.1576
Range -0.0464–0.0106 -1.1615–0.2945
% error
Mean ± SD -0.37 ± 0.33 -1.94 ± 1.66
95% CI -1.02–0.28 -5.20–1.32
Range -1.53–0.35 -9.06–2.30
Gd-concentration
Difference between actual and nominal values (mM)
Mean ± SD 0.0567 ± 0.0513 0.3298 ± 0.2897
95% CI -0.0439–0.1573 -0.2381–0.8976
Range -0.0532–0.2377 -0.3814–1.6963
% error
Mean ± SD 21.95 ± 18.45 21.85 ± 18.36
95% CI -14.22–58.11 -14.13–57.82
Range -17.48–78.17 -17.43–77.75
CER = contrast-enhancement ratio, Mean ± SD = average and standard deviation values, Range = minimum and maximum values, 95% CI = 
95% confidence interval
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Pre-Contrast R1 Value
The expected actual FA ranged between 1.54–2.10° for 
a nominal FA of 2° and 10.8–14.7° for a nominal FA of 
14°. By applying 100000 actual FAs within the 95% CI, the 
B1-error-influenced R1 values showed a variation range as 
summarized in Table 1 and Figure 2.
Typically, with a -10% FA error, the actual value of ‘m’ in 
Eq-3 measured in the gray matter was 0.9983 whereas its 
reference value was 0.9986 (e-R1 reference∙TR = e-0.549∙0.0025), thereby 
showing only a -0.03% error. However, according to Eq-4, as 
the actual R1 was 0.679 sec-1 ( 1TR∙ln [
1
m ] = 
1
0.0025∙ln [
1
0.9983]), 
the small error of ‘m’ was increased to a 23.6% R1 deviation.
Fig. 2. B1-inhomogeneity-induced variation of pre-contrast R1 in gray matter (reference value, 0.549 sec-1) and blood (reference 
value, 0.606 sec-1).
A. Distribution of actual values of pre-contrast R1 in gray matter. 95% CI of % error is -16.7–61.8%. B. Negative correlation between % error 
of FA and that of pre-contrast R1 in gray matter. Actual R1 is greater than reference value when actual FA was less than nominal FA, and vice 
versa. C. Distribution of actual values of pre-contrast R1 in blood. 95% CI of % error is -16.7–61.8%. D. Negative correlation between % error of 
FA and that of pre-contrast R1 in blood. Actual R1 is greater than reference value when actual FA was less than nominal FA, and vice versa. CI = 
confidence interval, FA = flip angle
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Gd-Driven CER
The time-dependent actual Gd-driven CERs are shown in 
Table 1 and Figure 3. The B1-error-induced deviation of CER 
was not notably high as the 95% CI of % error was only 
-1.02–0.28% in the gray matter and -5.20–1.32% in the 
blood. Typically, -10% FA error resulted in -0.400% error in 
the gray matter and -2.112% error in the blood.
The variation range of the actual CER became greater as 
the CER increased. For example, the range of the actual 
CER in the gray matter was 1.38–1.39 (95% CI of % error, 
-0.32–0.26%) at the nominal CER of 1.4, whereas it was 
2.98–3.02 (95% CI of % error, -1.20–0.32%) at the nominal 
CER of 3.
Gd-Concentration
The time-dependent actual Gd-concentrations are shown 
in Table 1 and Figure 4. Characteristically, a -10% FA 
deviation induced Gd-concentration errors of 23.6% in the 
gray matter and 23.5% in the blood.
The influence of the R1 and CER errors on the Gd-
Fig. 3. B1-inhomogeneity-induced variation of contrast-
enhancement ratio in gray matter and blood.
A. Reference and actual curves of time-dependent contrast-
enhancement ratio in gray matter. 95% CI of % error is -1.0–0.3%. B. 
Reference and actual curves of time-dependent contrast-enhancement 
ratio in blood. 95% CI of % error is -5.2–1.3%. CI = confidence 
interval
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Table 2. Simulation of Arterial Input Function
a1 (kg/L) a2 (kg/L) m1 (min-1) m2 (min-1)
Reference value 3.99 4.78 0.144 0.0111
Actual value
Mean ± SD 4.88 ± 0.79 5.85 ± 0.95 0.1438 ± 0.0002 0.0111 ± 0.0000
95% CI 3.33–6.44 3.99–7.71 0.1435–0.1441 0.0110–0.0111
Range 2.67–10.76 3.20–12.89 0.1428–0.1444 0.0109–0.0112
% error
Mean ± SD 22.40 ± 19.84 22.39 ± 19.81 -0.11 ± 0.11 -0.26 ± 0.28
95% CI -16.48–61.28 -16.43–61.22 -0.32–0.10 -0.80–0.28
Range -33.06–169.73 -33.04–169.66 -0.82–0.30 -1.98–1.09
Mean ± SD = average and standard deviation values, Range = minimum and maximum values, 95% CI = 95% confidence interval
Fig. 6. B1-inhomogeneity-induced variation of four parameters that characterize arterial input function. 
95% CI of % error are -16.5–61.3% for a1 (A), -16.4–61.2% for a2 (B), -0.3–0.1% for m1 (C), and -0.8–0.3% for m2 (D). CI = confidence interval
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concentration is compared in Figure 5, in which either of 
these two parameters was applied as a reference value and 
the other as an actual value. This simulation demonstrated 
that the R1 error caused a greater variation in the Gd-
concentration than in the CER. This is evident from the 
95% CI of the Gd-concentration being wider due to the pre-
contrast R1 error than the CER error.
The variation width of the actual Gd-concentration 
became greater as the Gd-concentration increased. For 
example, in the gray matter, the 95% CI of actual Gd-
concentration was 0.047–0.094 (% error, -19.20–63.33%) 
at a Gd-concentration of 0.058 mM, whereas it was 0.244–
0.493 (% error, -19.17–63.25%) at a Gd-concentration of 
0.302 mM.
AIF
The simulated AIF parameter, calculated by fitting the 
actual Gd-concentration curve, is presented in Table 2 
and Figure 6. Typically, a -10% FA error led to 23.44, 
23.43, -0.12, and -0.28% error of a1, a2, m1, and m2, 
respectively. In these simulations, the a1 and a2 values 
which characterize the amplitude of the AIF curve showed a 
greater FA-dependent variation (95% CI of % error, -16.48–
61.28%) than m1 and m2 (-0.80–0.28%) which describe the 
shape of the AIF curve.
PK Parameters
The distribution of the B1-error-influenced PK parameters 
is shown in Table 3. The 95% CI of % error was -43.1–
48.4% in the Ktrans, -43.2–48.6% in the ve, and -43.2–48.6% 
in the vp. Characteristically, a -10% FA error led to 17.51% 
error in the Ktrans, 17.49% in the ve, and 17.58% in the vp.
All of these parameters demonstrated a negative 
correlation with the % error of FA in that they were higher 
than the reference values when the actual FA was lower 
than the nominal FA.
Simulation Example
According to the simulation example, in which the FA 
error is 3% in a target lesion and -10% in a feeding vessel, 
the % error of the PK parameter was -23.66% for the Ktrans, 
-23.71% for the ve, and -23.70% for the vp. Detailed results 
are given in Figure 7.
DISCUSSION
This study analyzed the influence of B1-inhomogeneity on 
the PK modeling of DCE-MRI. In the phantom experiment on 
a 3T unit that undergoes regular vendor-guided equipment 
maintenance, a considerable range was observed in the 
actual FA (95% CI, -23–5%) with a nominal FA of 30°. 
Subsequently, Monte Carlo simulation using a similar FA 
variation demonstrated that the B1-inhomogeneity-induced 
incorrect measurement of pre-contrast R1 (-17–62%) as well 
as the Gd-driven CER (-5–1%) led to a substantial deviation 
of the Gd-concentration (-14–58%). Finally, our simulation 
demonstrated a significant variation in the PK parameters 
(-43–49%), which would be beyond a tolerable error range 
in clinical practice (16).
According to our simulation, the FA variation has a greater 
effect on the pre-contrast R1 measurement than on the 
CER. In this respect, a -10% FA deviation caused a 23.6% 
R1 error but only a -0.4% CER error in the gray matter. We 
suggest that this strong vulnerability of the pre-contrast R1 
to FA inhomogeneity is closely related to the calculation 
process in the VFA method. According to the Eq-4 and TR 
of 5 msec, R1 = 
1
TR∙ln (
1
m ) = 
1
0.0025∙ln (
1
m ) = 400∙ln (
1
m ). 
As such, multiplication of 1TR, i.e., 400, amplifies a small 
variation of ‘m’ to a substantial error of R1. For example 
in our simulation, only a -0.03% deviation of ‘m’ led to 
Table 3. Simulation of Pharmacokinetic Parameters
Ktrans (min-1) ve vp
Reference value 0.05 0.21 0.010
Actual value
Mean ± SD 0.0513 ± 0.0117 0.2155 ± 0.0491 0.0103 ± 0.0023
95% CI 0.0285–0.0742 0.1193–0.3117 0.0057–0.0149
Range 0.0196–0.1310 0.0820–0.5504 0.0039–0.0263
% error
Mean ± SD 2.67 ± 23.35 2.62 ± 23.43 2.71 ± 23.43
95% CI -43.10–48.44 -43.22–48.64 -43.22–48.64
Range -60.83–162.00 -60.94–163.03 -60.94–163.03
Mean ± SD = average and standard deviation values, Range = minimum and maximum values, 95% CI = 95% confidence interval
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a 23.6% error of R1. Moreover, as the pre-contrast R1 is 
used from the first step in converting the DCE-MRI SI to 
the Gd-concentration, its deviation continuously affects 
the subsequent calculations in the PK modeling. As shown 
in our simulation example, a 23.6% deviation of blood 
pre-contrast R1, which was induced by a -10% FA error, 
ultimately causes approximately -24% deviations of Ktrans, 
ve, and vp. Therefore, in order to improve the accuracy and 
reliability of PK parameter measurements, it is necessary to 
control the propagation of R1 error throughout a number of 
steps in the Gd-concentration estimation.
In order to reduce the undesirable effect of B1-
inhomogeneity on estimation of PK parameters, the 
application of B1-corrected R1 mapping is the primary 
recommended solution (20, 21). In a recent study the 
B1 field was accurately homogenized by a linear, inverse, 
distant-weighted interpolation. This study demonstrated 
that this B1 correction could reduce the difference in 
the in vivo T1 value, between the inversion recovery 
and VFA methods, from 58% to 8.1% in the breast coil 
Fig. 7. Example case that simulates actual situation reflecting influence of B1-inhomogeneity on pharmacokinetic modeling of 
DCE-MRI. In this simulation, target lesion in image center has 3% FA deviation and feeding vessel in image periphery has -10% FA deviation, 
which leads to measurement error occurring in each calculation step of pharmacokinetic modeling. Finally, % errors for pharmacokinetic 
parameters were -23.7% for Ktrans (A), -23.7% for ve (B), and -23.7% for vp (C). A. U. = arbitrary unit, CI = confidence interval, DCE-MRI = 
dynamic contrast-enhanced magnetic resonance imaging
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(21). According to Eq-3 and -4, such an 8.1% R1 error is 
approximately equivalent to an FA error of 4%. Therefore, 
the B1 correction can reduce not only the R1 deviation but 
also the CER error, thereby significantly improving the 
quality of PK modeling.
Applying a long TR in a condition that satisfies the 
acceptable scanning time can be another solution for 
reducing the variation of pre-contrast R1. Our simulation 
used a TR of 2.5 msec for the VFA method as recommended 
by the QIBA guidelines when using the same pulse sequence 
for R1 measurement as used for the DCE-MRI (16). However, 
as detailed in Eq-4, the use of a longer TR can reduce the 
effect of deviated ‘m’ while not disturbing the PK modeling. 
For example, a TR of 5 msec may reduce the effect of 
deviated ‘ln (1 / m)’ by half compared with a TR of 2.5 msec. 
A majority of two-compartment models analyze the shape 
of the time-concentration curve, and therefore are strongly 
dependent on the accuracy of the Gd-concentration. 
Therefore, these methods are inherently affected by the 
FA-dependent error, as described above. On the other 
hand, an algorithm that was initially proposed by Brix 
et al. (22) and then modified by Hoffmann et al. (23) 
estimates PK parameters directly from the DCE-MRI SI. 
Therefore, this method has an important advantage to avoid 
potential errors occurring during the measurement of pre-
contrast R1 and Gd-concentration. The feasibility of this 
simple approach as an alternative to the complex, two-
compartment models has been validated in several clinical 
trials (22, 24-26). Another benefit of this method is that 
there is no requirement for AIF measurement which has been 
seriously considered as a major error source in PK modeling 
(27). However, the usage of this algorithm is acceptable 
only under specific permeability-limiting conditions (17, 
28), and does not provide the blood volume. Therefore, a 
larger-scale verification regarding its strength and weakness 
is necessary, which must be based on a comparison with 
the concentration-based, two-compartment models.
In the present study, the B1-inhomogeneity was measured 
using a brain coil. As the B1-inhomogeneity increases in 
a larger field of view, the FA variation must be greater in 
the body and breast coils than in the brain coil. Actually, 
previous breast coil studies showed a wider deviation of FA 
(median, -40%; and greater than -50% in some cases) than 
this study (7, 10). Consequently, the variation of FA and 
the subsequent measurement error of PK parameters may be 
augmented when using the breast or body coil.
The influence of B1-inhomogeneity on PK parameter 
estimation from DCE-MRI was also simulated by Di Giovanni 
et al. (9) who showed a greater variation of the PK 
parameters than that seen in our study (for example, Ktrans 
and ve error up to 531% and 233%). For the simulation, they 
separately employed the deviated pre-contrast R1 and FA for 
DCE-MRI, which referred to the values seen in the literature 
reports. In contrast, our simulation applied such parameters 
originating from a single B1-inhomogeneity condition on 
the basis of a phantom experiment, and therefore may be 
more realistic for predicting an error occurring in each MRI 
unit. Moreover, again comparing with Di Giovanni et al. (9), 
this simulation included the deviation of AIF induced by FA 
error, and used the modified Tofts model that measures the 
vp. Although the etiology and phenomenon of unstable PK 
modeling are similarly considered, the dissimilar simulation 
setting seems to be the main cause of such different error 
ranges in the PK parameters from different studies. 
In conclusion, this study demonstrates the influences of 
B1-inhomogeneity on PK parameter estimation using DCE-
MRI. An understanding of the inherent FA error, which 
occurs even in clinically utilized MR units and its impact on 
PK modeling, will help to establish strategies for using DCE-
MRI to improve the quantification of disease- or treatment-
driven vascular alterations.
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